Author Archives: Marta Figueiredo

FDA Approves Darzalex Combo Therapy for Certain Newly Diagnosed Patients

The U.S. Food and Drug Administration (FDA) has approved Darzalex (daratumumab) in combination with standard therapy for the treatment of patients with newly-diagnosed multiple myeloma who are not eligible for stem cell transplants, according to Janssen Pharmaceuticals. Darzalex, created by Genmab, and developed and commercialized by Janssen Pharmaceuticals,…